Friday , 22 September 2017
Breaking News
Home » Health » Research Report and Overview on Digital Breast Tomosynthesis (DBT) System Market, 2016 – 2026
Research Report and Overview on Digital Breast Tomosynthesis (DBT) System Market, 2016 – 2026

Research Report and Overview on Digital Breast Tomosynthesis (DBT) System Market, 2016 – 2026

The digital breast tomosynthesis (DBT) system is used to create a 3-dimentional image of breast by using many low/high dose x-rays obtained at different angles. Digital breast tomosynthesis is similar to computed tomography imaging in which a number of images is taken to create a 3-D image of body. Mostly digital breast tomosynthesis used low dose of radiation, but for some procedures, digital breast tomosynthesis have higher level of radiation dose than that of standard mammography. Although, radiation dose remains within the criteria of safe dose levels of radiation as per the regulations. According to GLOBOCAN, 1.7 million cases of breast cancer were diagnosed worldwide in 2012. Incidence of breast cancer is increasing worldwide, and so the number of deaths due to breast cancer. Digital breast tomosynthesis helps to identify the breast cancers that cannot be identified with conventional mammography.

Digital Breast Tomosynthesis (DBT) System Market: Drivers and Restraints

Digital breast tomosynthesis system market is growing as the incidence of breast cancer is increasing rapidly worldwide. Major drivers for the digital breast tomosynthesis market is its accuracy over mammography to detect the cancer at an early stage. Other factors such as improvement in technology, increasing number of market players, and greater accuracy in detection of shape, location and size of breast abnormality are expected to boost the digital breast tomosynthesis system market growth rate in near future. However, high price, limited number of manufactures and lack of awareness in developing countries are the main restraint of the digital breast tomosynthesis system market growth.

Request free sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1241

Digital Breast Tomosynthesis (DBT) System Market: Segmentation

Digital breast tomosynthesis system’s global market is segmented into following segments –

By End User

Hospitals

500+ Beds

200-499 Beds

Less than 200 Beds

Diagnostic Centres

By Region

North America

Latin America

Western Europe

Eastern Europe

APEJ

Japan

MEA

Digital Breast Tomosynthesis (DBT) System Market: Overview

Digital breast tomosynthesis system market is growing with a healthy CAGR because of its high adoption rate in developed countries coupled with its greater accuracy over conventional mammography. More number of market players are expected to enter in the digital breast tomosynthesis system market in near future.

Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1241

Digital Breast Tomosynthesis (DBT) System Market: Region-wise Outlook

Depending on geographic region, global digital breast tomosynthesis system market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa.

North America contributes maximum in global digital breast tomosynthesis system market share. European countries showing a good growth as the adoption rate for digital breast tomosynthesis is increasing for detection of breast cancer at an early stage. Asia Pacific is growing with a slower CAGR for digital breast tomosynthesis system market due to lack of awareness and high price of digital breast tomosynthesis system. Amongst the European countries, Germany, U.K., and France are more promising due to increase in incidence of breast cancer in these countries.

Browse full report: http://www.futuremarketinsights.com/reports/digital-breast-tomosynthesis-dbt-system-market

Digital Breast Tomosynthesis (DBT) System Market: Key Players

Key players of digital breast tomosynthesis system market includes Hologic, Inc.,General Electric Company, Fujifilm Holdings Corporation, Planmed Oy,and Siemens AG, IMS S.r.l.

About fmiresearch

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>